Top 30 Biotechnology Angel Investors in Switzerland (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Penny Schiffer
Angel
|
4 | Switzerland, Germany, United Kingdom | Seed, Series A | Medical, Health Care, Finance | $544k–$9.3M |
|
Miklos Stanek
Angel
|
1 | Switzerland | Seed, Pre-Seed, Series A | Health Care, Biotechnology, Pharmaceutical | $5.8M–$8.2M |
|
Thomas Zehnder
Angel
|
1 | Switzerland | Seed | Health Care, Life Science, Biotechnology | |
|
Ted Kummert
Angel
|
1 | Switzerland | Series A | CRM, Big Data, Life Science | |
|
Nicolas Weber
Angel
|
1 | Switzerland | Pre-Seed | Genetics, Oncology, Generative AI | |
|
Thomas Glocer
Angel
|
1 | United States, United Kingdom, Israel | Seed, Series A, Series C | Software, FinTech, Analytics | $1M–$27M |
|
Reinhard Ambros
Angel
|
1 | United States, Switzerland | Series A, Series B, Series C | Biotechnology, Health Care, Pharmaceutical | |
|
John Zimmer
Angel
|
1 | United States, Switzerland | Series B, Seed | Mining, FinTech, Mineral | $30M–$193M |
|
Alexsis de Raadt-St. James
Angel
|
1 | United States, Switzerland, United Kingdom | Seed, Series A, Series B | Software, SaaS, Health Care | $250k–$24M |
|
Tobias Reichmuth
Angel
|
1 | Switzerland | Seed, Angel, Pre-Seed | E-Commerce, Travel, Internet | $138k–$2.9M |
|
Philip Wels
Angel
|
1 | Switzerland | Pre-Seed | Sports, Software, Information Technology | |
|
Piero Novelli
Angel
|
1 | Switzerland | Pre-Seed | Wellness, Neuroscience, Information Technology | |
|
Ian Metcalfe
Angel
|
1 | Switzerland | Pre-Seed | Biotechnology | |
|
Tej Tadi
Angel
|
1 | Switzerland | Seed | Robotics, Neuroscience | |
|
Emily Leproust
Angel
|
1 | Switzerland, United States | Seed | Biotechnology, Health Care, Product Research | $1.5M–$6M |
|
Chris Gibson
Angel
|
1 | United States, France, Switzerland | Series A, Seed | Biotechnology, Health Care, Life Science | $4.9M–$55M |
|
Lukas Speiser
Angel
|
1 | Germany, Switzerland | Seed | Wellness, Nutrition, Health Care | |
|
Beat Schillig
Angel
|
1 | Switzerland | Seed, Series A | Information Technology, SaaS, Music | $2.3M–$5.2M |
|
Christoph Behn
Angel
|
1 | Germany, Switzerland | Pre-Seed, Seed | Software, Manufacturing, Advanced Materials | $1.1M–$6.9M |
|
Lucian Wagner
Angel
|
1 | Switzerland | Seed | Skiing, Sports, Fitness | |
|
Walter Fischl
Angel
|
1 | Switzerland | Medical, Health Care, Biotechnology | ||
|
Mathias Maurer
Angel
|
1 | Switzerland | Pre-Seed | Wellness, Neuroscience, Information Technology | |
|
Peter Herger
Angel
|
1 | Switzerland | Pre-Seed | Wellness, Neuroscience, Information Technology | |
|
Nicolas Mermod
Angel
|
1 | Switzerland | Series A | Medical, Health Care, Life Science | |
|
Ulf Claesson
Angel
|
1 | Switzerland | Seed | Biotechnology, Food and Beverage | |
|
Thorsten Schroeder
Angel
|
1 | United States, Brazil, Switzerland | Seed, Series B | Children, Electronics, Life Science | $18M–$23M |
|
Arda Kara
Angel
|
1 | United States, Germany, Switzerland | Series A, Seed, Series B | Health Care, Medical, Software | $26M–$38M |
|
Patrick Delarive
Angel
|
1 | Switzerland | Seed | Security, Wireless, Wearables | |
|
Urs Berger
Angel
|
1 | Switzerland | Pre-Seed | Wellness, Neuroscience, Information Technology | |
|
Marcello Campanelli
Angel
|
1 | Switzerland | Pre-Seed | Biotechnology | |
| Access all 28 angel investors in Switzerland Biotechnology startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Penny Schiffer - CEO & Co-founder @ Raized.ai
Show more...Investment focus
- Industry: Medical, Health Care, Finance
- Stage:Seed, Series A
- Geography: Switzerland, Germany, United Kingdom
Investor stats
- Total investments: 34
- Round size: Seed $544k–$9.3M; Series A $1.2M–$7M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Versameb — Versameb AG is a preclinical-stage biopharmaceutical company located in Basel, Switzerland managed by an experienced scientific and business pharmaceutical industry team. The company’s focus is the development of novel RNA-based therapeutics. Versameb’s proprietary VERSagile technology platform enables efficient development of functional mRNAmolecules for customized protein expression and modification in multiple disease areas with high unmet medical need.
- Enterprise Bot — Cost-effective Conversational AI solutions transforming customer interaction for global enterprises. Discover cutting-edge chat, email, and voice tech.
- Scientific Visual — Scientific Visual supplies quality control workstations to visualize defects in non-polished sapphire such as watch covers, ingots and wafers.
Miklos Stanek joined BackBone Ventures as Founding Partner & Chairman.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Pharmaceutical
- Stage:Seed, Pre-Seed, Series A
- Geography: Switzerland
Investor stats
- Total investments: 6
- Round size: Series A $5.8M–$8.2M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Neon — With neon, you can pay, save and manage your money. Digitally, securely and with no hidden fees. Open your account online in less than 10 minutes!
- ImmunOs Therapeutics — ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.
Thomas Zehnder - Partner @ BlueOcean Ventures
Show more...Investment focus
- Industry: Health Care, Life Science, Biotechnology
- Stage:Seed
- Geography: Switzerland
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Testmate Health — 2 in 1 urine test with immediate results for Chlamydia trachomatis and Neisseria gonorrhoeae. Results within minutes & 100% anonymous.
Ted joined Madrona in 2013 and brings his years of technical and operational leadership in enterprise technology to Madrona and the portfolio companies. As Venture Partner, Ted identifies new investments and provides strategic counsel and operational advice to Madrona portfolio companies. Prior to Madrona, Ted drove major product and businessinitiatives for Microsoft for more than two decades. At Microsoft, Kummert led teams across a broad set of technologies, including operating systems, consumer online services, enterprise security and enterprise application platform. As Corporate Vice President of the Data Platform Group, Kummert led the development of several key Microsoft enterprise products including SQL Server, SQL Server Parallel Data Warehouse, Windows Azure Data Services and Microsoft's business intelligence and big data offerings. Widely known as the "data chief" of Microsoft, he led the data platform business through a period of significant growth and drove the cloud and big data strategy for the platform. Ted began his career at Apple and HP.
Show more...Investment focus
- Industry: CRM, Big Data, Life Science
- Stage:Series A
- Geography: Switzerland
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Veezoo — Veezoo empowers individuals to find actionable insights from data by literally just asking questions in plain English!
Healthcare has been my passion throughout most of my professional life – in international corporate environments and as entrepreneur and Business Angel. I co-founded medneo (https://www.medneo.com/) (Radiology as a Service) and OpenRad (https://www.openrad.com/) (IT rails for diagnostic imaging) and helped to buildit from zero to 550+ people – what a journey. I recently transitioned from Group CEO to the supervisory board. With medneo (https://www.medneo.com/) we are improving access to high-end diagnostic imaging (e.g. MRI, CT, etc.) for patients with a new pan-European operating model for medical service providers: Radiology as a Service. And with OpenRad (https://www.openrad.com/) we bring workflow IT to 3rd party diagnostic centers beyond medneo. I have developed the organization for CEOs to manage the brands independently and I support them actively as board director. Together with my two co-founders André Glardon (https://www.linkedin.com/in/andreglardon/) and Matthias Issing (https://www.linkedin.com/in/matthias-issing/) we – 3minds (https://www.linkedin.com/company/3minds-projects/) – are supporting outstanding impact entrepreneurs on their journey to improve our lives - as angels, mentors and in board functions. We engage directly and via amazing networks like Better Ventures (https://www.betterventures.io/) and Springboard Health (https://www.springboardangels.com/). I'm a grateful member of the Entrepreneurs' Organization (https://eonetwork.org) - the meaningful connections with diverse and inspiring people helped me to grow as a person. Also, I'm a board member of EO's Berlin Chapter (https://www.eoberlin.com/). Berlin (https://goo.gl/maps/6zP6kaWtrY7VQhvu6) based. Originally from the south of Germany (Pforzheim), had the opportunity to live and work abroad (e.g. USA, UK, China). I like endurance sports, especially long-distance running (Marathon+) and cycling. I'm happy to contribute and connect (https://about.me/nicolas.weber) - feel free to reach out! https://www.linkedin.com/in/nicolasweber/
Show more...Investment focus
- Industry: Genetics, Oncology, Generative AI
- Stage:Pre-Seed
- Geography: Switzerland
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Qnomx — Reduce expert workload per NGS case by up to 85%. Qnomx leverages AI to streamline NGS interpretation and generate clinician-ready reports.
Tom Glocer joined BlueVoyant as Executive Chairman and Founder in 2017.
Show more...Investment focus
- Industry: Software, FinTech, Analytics
- Stage:Seed, Series A, Series C
- Geography: United States, United Kingdom, Israel
Investor stats
- Total investments: 52
- Round size: Seed $1M–$13M; Series A $5M–$24M; Series C $13M–$27M
- Lead/follow: 2% lead, 98% follow
Portfolio highlights
- Superlegal — Superlegal, the world's #1 contract automation platform, is the fastest, easiest and most cost effective way to negotiate and close deals.
- Cradle — Using robust prediction algorithms and AI design recommendations, Cradle assists biologists in rapidly designing better proteins. Cradle gives you complete ownership of the intellectual property while maintaining the privacy and security of your sequences and data.
- Black Ore Technologies — Black Ore's Tax Autopilot is the first AI tax platform for CPAs, offering complete 1040 tax preparation automation to tax professionals, so they can focus on growing their firm.
Reinhard Ambros
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series A, Series B, Series C
- Geography: United States, Switzerland
Investor stats
- Total investments: 11
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- FORMA Therapeutics — FORMA Therapeutics is a biopharmaceutical company integrating transformative biology and chemistry to unlock targets and pathways that have been validated through genomic medicine as root causes or major drivers of human cancers.FORMA’s approach to accessing such high value drug targets, many of which pose significant challenges toconventional discovery approaches, is rooted in the concerted integration of its innovative drug discovery technologies and oncology expertise, enabling screening, discovery and rational development of a generation of small molecule drug candidates with cellular mechanisms of action. FORMA is building a pipeline of therapeutics directed at Achilles heels in human cancers, such as key targets associated with cancer stem cells, tumor cell metabolism, programmed cell death or epigenetic disease mechanisms.FORMA builds on the vision of its academic founders: Stuart Schreiber, Todd Golub and Michael Foley, each of the Broad Institute of Harvard and MIT. FORMA leverages its innovative drug discovery platform to address challenging targets and develop a robust internal pipeline of breakthrough oncology drugs.
- Aileron Therapeutics — Aileron Therapeutics - ALRN-6924 - myelopreservation
- ImmunOs Therapeutics — ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.
John Zimmer is the co-founder and President of Lyft, the on-demand ridesharing platform, that was founded in 2007 with Zimride as its first of two products built to create a more social, sustainable and affordable transportation system. John’s interest in peer-to-peer transportation began at Cornell’s School of Hotel Administration. Uponlearning that only 20% of seats in cars on highways are occupied, he began working on ways to use existing information infrastructures to solve the problem of unused empty seats. After graduating first in his class, John spent two years at Lehman Brothers before (luckily) leaving to rideshare his way from New York to San Francisco to join co-founder Logan Green in launching Zimride. John was recognized in 2009 as one of Businessweek's Top 25 Entrepreneurs Under 25, and has spoken at top tier events such as SXSW, The Association for Commuter Transportation (ACT) International Conference and Stanford Business School. With Lyft, John hopes to fix the current state of transportation across the country, and eventually around the world, to make cities safer, more affordable and better connected. Since unveiling the product in June 2012, Lyft has quickly become one of the fastest-growing tech companies with more than $80 million raised from leading investors Andreessen Horowitz and Founders Fund and has been featured in The Economist, the New York Times and on NBC’s TODAY Show. Lyft is currently available in San Francisco, Los Angeles, Seattle, San Diego, Chicago, Boston and Washington, D.C., with more than a million rides shared on the platform to date.
Show more...Investment focus
- Industry: Mining, FinTech, Mineral
- Stage:Series B, Seed
- Geography: United States, Switzerland
Investor stats
- Total investments: 3
- Round size: Series B $30M–$193M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Deel — With Deel, your business can easily hire anywhere. No more worrying about local laws, complex tax systems, or managing international payroll. Deel takes care of everything in 150+ countries.
- Cradle — Using robust prediction algorithms and AI design recommendations, Cradle assists biologists in rapidly designing better proteins. Cradle gives you complete ownership of the intellectual property while maintaining the privacy and security of your sequences and data.
- KoBold Metals — Finding the materials of the future with AI and HI
Alexsis is the Founder and Managing Partner of Merian Ventures, an early-stage venture firm focused on investing in women founded, co-founded and majority-owned companies in the US and UK. Alexsis has extensive investment, venture and operations experience based on businesses she has founded or funded. As managing partner of Merian Ventures since2015, Alexsis serves as a Board Member and Advisor to Merian Venture portfolio companies Provenance, Pivigo, Populus, Honeycomb, ImpactVision, CareerLark, Cirrus Identity and Compaas, among others. Merian Ventures was named after Maria Sibylla Merian, a botanist, entrepreneur and intrepid traveler born in 1647. In addition to Merian Ventures, Alexsis is a US-UK Fulbright Commissioner; Board member of the Oxford Internet Institute; Board member of The Oxford Foundry; Founder and funder of the WEInnovate STEM accelerator for Women at Imperial College, London; and Board Member and Advisor to companies she's funded. Alexsis is also Chairman and Founder of The Althea Foundation, established in 2003 as a family office. Today, The Althea Foundation is a California nonprofit public benefit corporation and it is recognized by the Internal Revenue Service as a public charity described in Internal Revenue Code Sections 501(c)(3) and 509(a)(1).
Show more...Investment focus
- Industry: Software, SaaS, Health Care
- Stage:Seed, Series A, Series B
- Geography: United States, Switzerland, United Kingdom
Investor stats
- Total investments: 8
- Round size: Seed $250k–$2.9M; Series A $2.1M–$24M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Aiden — Reduce risk, enhance compliance, and simplify IT with modern, intelligent software packaging and deployment using Artificial Intelligence.
- Compaas — Compaas: The Compensation Platform | Total Visibility. Zero Spreadsheets. Painless raise cycles, compensation metrics, people analytics, rewards letters
- Provenance — Provenance is a software solution for sustainability communications and supply chain transparency.
Tobias Reichmuth - Founding Partner at Maximon - The Longevity Company Builder @ Maximon
Show more...Investment focus
- Industry: E-Commerce, Travel, Internet
- Stage:Seed, Angel, Pre-Seed
- Geography: Switzerland
Investor stats
- Total investments: 8
- Round size: Seed $350k–$2.9M; Angel $138k–$1.7M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Firstcar — Firstcar provides car driving learning assistant services. They offer services that include hand-picked driving schools, student cars with double pedals for rent before and for the driving test, entry-level vehicles that are inexpensive to buy and maintain, support and advice on vehicle purchase, and selected insurances with special rates.
- MyFeld.ch — MyFeld.ch is the holder of a fresh farm food platform that aims to create a digital link between consumers and our local agriculture. The company's platform provides products directly from the farm, allowing people to improve their comprehension of seasonality and regionality while also raising awareness of the sustainable use of food byallowing them to purchase fresh produce from the farm.
- Testmate Health — 2 in 1 urine test with immediate results for Chlamydia trachomatis and Neisseria gonorrhoeae. Results within minutes & 100% anonymous.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Philip Wels is an individual investor.
Show more...Investment focus
- Industry: Sports, Software, Information Technology
- Stage:Pre-Seed
- Geography: Switzerland
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- BreezeLabs — Most runners track their performance.
- MindMetrix — MindMetrix is a startup project team of ETH Zurich which envisions products that quantify the performance of your mind and mental wellbeing.
Piero Novelli is the Chairman-Supervisory Board at Euronext NV.
Show more...Investment focus
- Industry: Wellness, Neuroscience, Information Technology
- Stage:Pre-Seed
- Geography: Switzerland
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- MindMetrix — MindMetrix is a startup project team of ETH Zurich which envisions products that quantify the performance of your mind and mental wellbeing.
Ian Metcalfe is an individual investor.
Show more...Investment focus
- Industry: Biotechnology
- Stage:Pre-Seed
- Geography: Switzerland
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- CellX Biosolutions — CellX Biosolutions harnesses bacteria to sustainably treat chemical waste including PFAS, pharmaceuticals, and microplastics, offering innovative, eco-friendly waste management solutions.
Tej Tadi is an Electronics Engineer and has pursued an advanced master in Virtual Reality & Computer Graphics at The Swiss Federal Institute of Technology (EPFL), Switzerland. During his PhD (EPFL), he set up an immersive virtual reality system in combination with state-of-the-art brain imaging technologies enabling trans-disciplinary work incognitive psychology, neuroimaging, and virtual reality. His research has led to important and highly visible scientific publications (Science) and awards (Pfizer Award for Neuroscience in 2009). Through his research, he has built a strong multi-disciplinary base spanning computer science, systems biology, neuroimaging, and computational and cognitive neuroscience. He founded MindMaze in 2011 to design and develop novel applications in Neuro-Rehabilitation, Game training & Interfaces. The technology platform from MindMaze will help in the neurology, psychiatry and sports rehabilitation.
Show more...Investment focus
- Industry: Robotics, Neuroscience
- Stage:Seed
- Geography: Switzerland
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Metaphysiks — Metaphysiks is a groundbreaking immersive technology company combining world leading neuroscience and robotics to create multisensory experiences.
As an early pioneer in long DNA synthesis, Emily is poised to accelerate the biofactory market. She and co-founder Bill Peck share the world record for synthesizing the longest, highest quality oligo library. Emily architected the successful SureSelect product line which lowered the cost of sequencing and elucidated dozens of mendelian diseases,and she developed Agilent’s Oligo Library Synthesis technology. Emily has co-authored over 34 peer-reviewed papers—many on synthetic DNA—and has extensive marketing, management, and business development experience. Prior to Twist Bioscience, Emily was Director of Applications and Chemistry R&D—Genomics at Agilent Technologies.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Product Research
- Stage:Seed
- Geography: Switzerland, United States
Investor stats
- Total investments: 3
- Round size: Seed $1.5M–$6M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Biostate AI — Biostate AI develops generative AI that benefit all human health.
- Cradle — Using robust prediction algorithms and AI design recommendations, Cradle assists biologists in rapidly designing better proteins. Cradle gives you complete ownership of the intellectual property while maintaining the privacy and security of your sequences and data.
- Kiwi Biosciences — Kiwi biosciences is a biotech company that develops enzymes to make food for patients who suffer from Irritable Bowel Syndrome (IBS). The company was founded in 2020 and is based in Somerville, Massachusetts, United States.
Chris Gibson is the Co-Founder and CEO of Recursion (Recursion Pharmaceuticals). He previously worked at Cure HHT as a Member Board of Directors. Chris Gibson attended the University of Utah.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Life Science
- Stage:Series A, Seed
- Geography: United States, France, Switzerland
Investor stats
- Total investments: 10
- Round size: Seed $4.9M–$14M; Series A $6.3M–$55M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Inato — Inato matches the right sites to the right clinical research study, globally.
- Known Medicine — Known Medicine is looking to take the experimentation of how tumors respond to cancer drugs out of the patient’s body and into the lab. The startup breaks down tumor samples into micro tumors, which they treat separately inside specialized micro-environments with different methods and see what works best.
- Leash Biosciences — We're transforming drug design with a rich dataset built by screening millions of compounds against thousands of protein to generate billions of data points, ideal for training advanced machine learning models.
Lukas Speiser is the founder and CEO of Amorana.ch
Show more...Investment focus
- Industry: Wellness, Nutrition, Health Care
- Stage:Seed
- Geography: Germany, Switzerland
Investor stats
- Total investments: 4
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- feey — feey is a houseplant shop. They offer plants that include entry-level plants, baby plants, animal-friendly plants, large plants, home office plants, hanging plants, aglaonema, alocasia, calathea, hoya, monstera, and philodendron.
- Sleepiz — Sleepiz is a Zürich based startup with the aim to enable the medical community to take healthcare into the home environment. Sleepiz provides an easy and comfortable to use solution with a device that is simply placed on the bedside table. The device operates in a non-contact fashion and measures movements originating from heart contractions andbreathing patterns as well as body motions with medical grade accuracy.By making use of wireless millimeter wave technology, sensor fusion and artificial intelligence Sleepiz will in the future not only able to diagnose sleep disorders, but also to perform long-term monitoring. Thereby, the progression of chronic diseases can be monitored to allow faster intervention and better treatment.
- Dunatura — Dunatura engages in the manufacture and supply of vitamins and micronutrients.
Beat Schillig - Founder @ Venture Kick
Show more...Investment focus
- Industry: Information Technology, SaaS, Music
- Stage:Seed, Series A
- Geography: Switzerland
Investor stats
- Total investments: 3
- Round size: Seed $2.3M–$5.2M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- TYXIT — TYXIT is linking musicians wirelessly without configuration, allowing a personal audio monitoring.
- PXL Vision — PXL Vision enables state-of-the-art digital identity verification. PXL Vision's highly flexible technology solution helps global customers build trust digitally...
- 1Drop Diagnostics — 1Drop Diagnostics is a cutting edge medical diagnostics and life science company. They combine the best techniques from microfluidics, biochemistry, photonics and information technology to build high performance point-of-care diagnostics devices.Their vision is to provide high quality medical information for everyone. They aim to increase accessto quality healthcare by providing laboratory quality, easy to use, medical diagnostics in any setting. The 1Drop Diagnostics system is being developed for a broad menu of clinical applications including multiplexed assays of proteins, nucleic acids and peptides. Their first clinical applications are in the screening, diagnostics and monitoring of cardiovascular disease and infectious disease.Their mission is to improve patient lives by enabling precision medicine through non-invasive diagnostic tests providing actionable health information that is accessible to everyone at any time. They facilitate the early detection, prevention and management of disease. They empower people to live better lives.
Christoph Behn is the Chairman & Founder of better ventures. He previously worked at Die Kartenmacherei as an Advisory Board & Founder. Christoph Behn attended HHL Leipzig Graduate School of Management.
Show more...Investment focus
- Industry: Software, Manufacturing, Advanced Materials
- Stage:Pre-Seed, Seed
- Geography: Germany, Switzerland
Investor stats
- Total investments: 12
- Round size: Seed $3.3M–$6.9M; Pre-Seed $1.1M–$2M
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- 42watt — 42 Watt is an energy conservation consultancy which strives to reduce costs, save energy and protect the climate.
- Strollme — Strollme believes in idea of using resources wisely, they started with stroller which can be reused for next time.
- Qnomx — Reduce expert workload per NGS case by up to 85%. Qnomx leverages AI to streamline NGS interpretation and generate clinician-ready reports.
Lucian has a truly global outlook with an extensive set of contacts in North America, Europe, and Asia. Lucian is a venture capitalist and entrepreneur with several successful start-ups to his credit. He has 20 years of semiconductor industry experience. Lucian was born in Germany, educated in the French school system, and went on to earn a B.Sc.in International Economics from the School of Foreign Service at Georgetown University (with a minor in Russian) and an MBA from INSEAD.
Show more...Investment focus
- Industry: Skiing, Sports, Fitness
- Stage:Seed
- Geography: Switzerland
Investor stats
- Total investments: 2
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Adiposs — Adiposs is a Swiss biotech start-up company developing medical imaging products and technologies for early detection of cachexia.
- Snowcookie — Ski tracking sensors by bode miller for racers and coaches
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Walter Fischl
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Geography: Switzerland
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- ProteoMediX — ProteoMediX is a spinoff company of ETH Zurich and specialized in the identification of novel biomarkers for the early detection of cancer and the personalized treatment thereof.The first product currently developed is a blood-based test that enables the diagnosis of prostate cancer with significantly higher accuracy than today's clinicalstandard.This reduces unnecessary biopsies and thus results in significant cost savings for the healthcare system and less discomfort for the patient.
Mathias Maurer
Show more...Investment focus
- Industry: Wellness, Neuroscience, Information Technology
- Stage:Pre-Seed
- Geography: Switzerland
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- MindMetrix — MindMetrix is a startup project team of ETH Zurich which envisions products that quantify the performance of your mind and mental wellbeing.
Peter Herger is a private investor.
Show more...Investment focus
- Industry: Wellness, Neuroscience, Information Technology
- Stage:Pre-Seed
- Geography: Switzerland
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- MindMetrix — MindMetrix is a startup project team of ETH Zurich which envisions products that quantify the performance of your mind and mental wellbeing.
Nicolas Mermod
Show more...Investment focus
- Industry: Medical, Health Care, Life Science
- Stage:Series A
- Geography: Switzerland
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- NewBiologix — NewBiologix operates as a technology innovation company, develops a proprietary and breakthroughDNA integration platform for the advanced engineering of human and mammaliancell lines.
Ulf Claesson is a Partner (since 2009) at BLR & Partners AG, a private equity firm located in Zurich, Switzerland. From 2006 to 2009, Ulf built up and ran one of HP’s product divisions as a General Manager and Vice President after having one of his companies acquired by Hewlett-Packard Corporation. From 2002 to 2006, Ulf was Co-founderand Chairman of the Board of Directors at Silverwire Group (now a Hewlett-Packard Company). Ulf has served as a Member of the Board of Directors at AVAST Software since October 2012. Prior to co-founding Silverwire Group, in 1997 Ulf founded Whitecap GmbH and Whitecap LLP, where he also serves as Managing Director to this day. From 1977 to 1997, Ulf served in various European and global management and executive positions at IBM Corporation, where he, among other new business segments, built up IBM’s global Distribution business and its OEM business in Continental Europe. Ulf also serves as a Member of the Board of the Swiss Federal Commission for Innovation and Technology and is a Lecturer, teaching Entrepreneurship at the Swiss Federal Institute of Technology in Zurich. Ulf holds a M.Sc. degree from Chalmers University of Technology in Gothenburg, Sweden.
Show more...Investment focus
- Industry: Biotechnology, Food and Beverage
- Stage:Seed
- Geography: Switzerland
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- MIRAI FOODS — Love meat? Mirai aims to produce the meat of the future by cultivating animal cells in a controlled environment
Thorsten Schroeder
Show more...Investment focus
- Industry: Children, Electronics, Life Science
- Stage:Seed, Series B
- Geography: United States, Brazil, Switzerland
Investor stats
- Total investments: 9
- Round size: Series B $18M–$23M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Storypod — The screen-free, educational audio toy that engages children independently & makes learning fun. Storypod delights toddlers, preschoolers, 1st, & 2nd graders with music, stories, songs, audiobooks, & podcasts. The Storypod audio player features recording from any phone, bedtime nightlight, sound machine, & white noise.
- TROCAFONE — Trocafone is the first end-to-end e-commerce marketplace of LATAM that enable people to buy and sell used electronics hassle free, focused on smartphones in Brazil. At Trocafone they improve the selling and buying experience by acquiring the devices from sellers, refurbishing and re-selling them as pre-owned certified. Buyers enjoy the greatdeals of a peer-to-peer marketplace combined with the service, convenience, and safety of a retail store. Sellers enjoy a streamlined experience since It takes seconds to sell an item, and shipping is effortless with Trocafone's pre-addressed, pre-stamped mailers.
- 4D Lifetec — 4D Lifetec is a biotechnology company promoting and developing screening and test systems for molecular diagnostics. It also offers a unique solution for DNA defect and repair based screening programs and is, therefore, the diagnostic method of the first choice. The company profits from different networks in science and healthcare.4D Lifetecprovides kits, reagents, download center, 4D life tanks, and service packages. They also offer cost savings for healthcare provider by its outstanding precision and a high degree of standardization both leading to a reduction of false positive results.4D Lifetec was founded by Dr. Arne Faisst and Nick Mijnssen in 2014 and is headquartered in Cham, Zug.
Arda Kara
Show more...Investment focus
- Industry: Health Care, Medical, Software
- Stage:Series A, Seed, Series B
- Geography: United States, Germany, Switzerland
Investor stats
- Total investments: 9
- Round size: Series A $26M–$38M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Human API — Health data platform that connects to all data sources, enabling companies to build new technologies & deliver better experiences to customers.
- Levels — Improve metabolic health with CGM, comprehensive labs, and a personalized plan.
- Blackrock Neurotech — Blackrock Neurotech innovative brain technologies provide new hope for people with paralysis & other neurological disorders.
Patrick is a businessman active in real estate, wealth management, show business, hospitality, education and private equity, benefiting from a strong network. At Biowatch since November 2015.
Show more...Investment focus
- Industry: Security, Wireless, Wearables
- Stage:Seed
- Geography: Switzerland
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Biowatch — Biowatch is a user-friendly wrist veins biometric reader that functions as a security solution for mobile payment protection and smart device interaction. Users can access the app for enrolling their vein pattern and selecting applications and devices that needs to be connected to their Biowatch, wear their BioWatch and activate it by matchingtheir vein pattern with their enrolled reference, get PKI encrypted user code transmitted from their Biowatch, and start opening doors without the use of keys and passwords.Biowatch was launched by Joe Rice and Matthias Vanoni and is headquartered in Lausanne, Switzerland.
Urs Berger is the current President of Swiss Entrepreneurs Foundation. He previously worked at JAROWA AG as a Chairman of the Board. Urs Berger attended Northwestern University - Kellogg School of Management.
Show more...Investment focus
- Industry: Wellness, Neuroscience, Information Technology
- Stage:Pre-Seed
- Geography: Switzerland
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- MindMetrix — MindMetrix is a startup project team of ETH Zurich which envisions products that quantify the performance of your mind and mental wellbeing.
Marcello Campanelli is a general manager at Parker Lord.
Show more...Investment focus
- Industry: Biotechnology
- Stage:Pre-Seed
- Geography: Switzerland
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- CellX Biosolutions — CellX Biosolutions harnesses bacteria to sustainably treat chemical waste including PFAS, pharmaceuticals, and microplastics, offering innovative, eco-friendly waste management solutions.
Biotechnology Angel investor funding in Switzerland at a glance
Stats across 22 deals from 28 investors.
Access all 28 angel investors in Switzerland Biotechnology startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotechnology Angel Investors in Switzerland investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 28 angel investors investing in Switzerland Biotechnology startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!